Evolent Health (EVH) Short-term Investments (2015 - 2026)

Evolent Health's Short-term Investments history runs 12 years deep, the most recent figure standing at $24.0 million for Q1 2026.

• On a quarterly basis, Short-term Investments fell 23.39% year-over-year to $24.0 million in Q1 2026; TTM through Mar 2026 was $24.0 million, a 23.39% decrease from a year earlier, with the FY2025 full-year figure at $26.1 million, down 55.93% from the prior year.
• Short-term Investments fell to $24.0 million in Q1 2026 per EVH's latest filing, from $26.1 million in the prior quarter.
• Across five years, Short-term Investments topped out at $87.4 million in Q2 2022 and bottomed at $13.8 million in Q4 2023.
• The 5-year median for Short-term Investments is $34.5 million (2023), against an average of $40.2 million.
• Across the five-year window, Short-term Investments plunged 69.59% in 2022 and soared 330.67% in 2024, its largest moves.
• Year by year, Short-term Investments stood at $27.0 million in 2022, then plunged by 48.93% to $13.8 million in 2023, then jumped by 330.67% to $59.3 million in 2024, then slumped by 55.93% to $26.1 million in 2025, then dropped by 8.25% to $24.0 million in 2026.
• Per Business Quant, the three latest EVH Short-term Investments figures stand at $24.0 million (Q1 2026), $26.1 million (Q4 2025), and $23.7 million (Q3 2025).